Methods for Retrospective Detection of Exposure to Toxic Scheduled Chemicals. Part B: Mass Spectrometric and Immunochemical Analysis of Covalent Adducts to Proteins and DNA

Chemical Weapons Convention Chemicals Analysis: Sample Collection, Preparation and Analytical Methods

Volumn , Issue , 2006, Pages 433-451

  Noort, D ^a   Black, R M ^b  

^a TNO   (Netherlands)

^b DEFENCE SCIENCE AND TECHNOLOGY LABORATORY   (United Kingdom)

Author keywords

Biomedical sample analysis; Chemical Warfare Agent (CWA); Direct detection method; Fluoride reactivation method; Lewisite; Micro LC tandem MS; P postlabeling and immunoassays; Pulmonary agent phosgene; Sulfur mustard (mustard gas)

Indexed keywords

CHEMICAL WARFARE; FLUORINE COMPOUNDS; MASS SPECTROMETRY;

CHEMICAL WARFARE AGENTS; DIRECT DETECTION; FLUORIDE-REACTIVATION METHOD; LEWISITE; MICRO-LC; MUSTARD GAS; PULMONARY AGENT PHOSGENE; SAMPLE ANALYSIS;

CHEMICAL DETECTION;

EID: 84889474841     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/0470012285.ch17     Document Type: Chapter

References (56)

1. D. Noort, H.P. Benschop and R.M. Black, Biomonitoring of exposure to chemical warfare agents: a review. Toxicol. Appl. Pharmacol., 184, 116-126 (2002).
2. H. Koc and J.A. Swenberg, Application of mass spectrometry for quantitation of DNA adducts, J. Chromatogr., B, 778, 323-343 (2002).
3. M. Törnqvist, C. Fred, J. Haglund, H. Helleberg, B. Paulsson and P. Rydberg, Protein adducts: quantitative and qualitative aspects of their formation, analysis and applications, J. Chromatogr., B, 778, 279-308 (2002).
4. P.J. Boogaard, Use of haemoglobin adducts in exposure monitoring and risk assessment, J. Chromatogr., B, 778, 309-322 (2002).
5. P. Brookes, P.D. Lawley, The reaction of mustard gas with nucleic acids in vitro and in vivo, Biochem. J., 77, 478-484 (1960).
6. A. Fidder, G.W.H. Moes, A.G. Scheffer, G.P. Van der Schans, R.A. Baan, L.P.A. De Jong and H.P. Benschop, Synthesis, characterization and quantitation of the major adducts formed between sulfur mustard and DNA of calf thymus and human blood, Chem. Res. Toxicol., 7, 199-204 (1994).
7. A. Fidder, D. Noort, L.P.A. De Jong, H.P. Benschop and A.G. Hulst, N7-(2-Hydroxyethylthioethyl)-guanine: a novel urinary metabolite following exposure to sulfur mustard, Arch. Toxicol., 70, 854-855 (1996).
8. M.K. Rao, P.S. Bhadbury, M. Sharma, R.S. Dangi, A.S.B. Bhaskar, S.K. Raza and D.K. Jaiswal, A facile methodology for the synthesis and detection of N7-guanine adduct of sulfur mustard as a biomarker, Can. J. Chem., 80, 504-509 (2002).
9. D.B. Ludlum, P. Austin-Ritchie, M. Hagopian, T.-Q. Niu and D. Yu, Detection of sulfur mustard-induced DNA modifications, Chem.-Biol. Interact., 91, 39-49 (1994).
10. T. Niu, Z. Matijasevic, P. Austin-Ritchie, A. Stering and D.B. Ludlum, A 32P-postlabeling method for the detection of adducts in the DNA of human fibroblasts exposed to sulfur mustard, Chem.-Biol. Interact., 100, 77-84 (1996).
11. G.P. Van der Schans, A.G. Scheffer, R.H. Mars-Groenendijk, A. Fidder, H.P. Benschop and R.A. Baan, Immunochemical detection of adducts of sulfur mustard to DNA of calf thymus and human white blood cells, Chem. Res. Toxicol., 7, 408-413 (1994).
12. J.P. Langenberg, G.P. Van der Schans, W.E.T. Spruit, W.C. Kuijpers, R.H. Mars-Groenendijk, H.C. Van Dijk-Knijnenburg, H.C. Trap, H.P. Van Helden, and H.P. Benschop, Toxicokinetics of sulfur mustard and its DNA-adducts in the hairless guinea pig, Drug Chem. Toxicol., 21(Suppl. 1), 131-147 (1998).
13. H.P. Benschop, G.P. Van der Schans, D. Noort, A. Fidder, R.H. Mars-Groenendijk and L.P.A. De Jong, Verification of exposure to sulfur mustard in two casualties of the Iran-Iraq conflict, J. Anal. Toxicol., 21, 249-251 (1997).
14. J.L. Hambrook, D.J. Howells and C. Schock, Biological fate of sulfur mustard (1,1-Thiobis(2-chloroethane)): uptake, distribution and retention of 35S in skin and in blood after cutaneous application of 35S-sulfur mustard in rat and comparison with human blood in vitro, Xenobiotica, 23, 537-561 (1993).
15. G.P. Wheeler, Studies related to the mechanisms of action of cytotoxic alkylating agent: a review, Cancer Res., 22, 651-688 (1962).
16. D. Noort, E.R. Verheij, A.G. Hulst, L.P.A. De Jong and H.P. Benschop, Characterization of sulfur mustard induced structural modifications in human hemoglobin by liquid chromatographytandem mass spectrometry, Chem. Res. Toxicol., 9, 781-787 (1996).
17. R.M. Black, J.M. Harrison and R.W. Read, Biological fate of sulfur mustard: in vitro alkylation of human haemoglobin by sulfur mustard, Xenobiotica, 27, 11-32 (1997).
18. M. Törnqvist, J. Mowrer, S. Jensen and L. Ehrenberg, Monitoring of environmental cancer initiators through hemoglobin adducts by a modified Edman degradation method, Anal. Biochem., 154, 255-266 (1996).
19. A. Fidder, D. Noort, A.L. De Jong, H.C. Trap, L.P.A. De Jong, H.P. Benschop, Monitoring of in vitro and in vivo exposure to sulfur mustard by GC/MS determination of the N-terminal valine adduct in hemoglobin after a modified Edman degradation, Chem. Res. Toxicol., 9, 788-792 (1996).
20. R.M. Black, R.J. Clarke, J.M. Harrison and R.W. Read, Biological fate of sulfur mustard: identification of valine and histidine adducts in haemoglobin from casualties of sulfur mustard poisoning, Xenobiotica, 27, 499-512 (1997).
21. H.P. Benschop, D. Noort, G.P. Van der Schans, L.P.A. De Jong, 'Diagnosis and Dosimetry of Exposure to Sulfur Mustard: Development of Standard Operating Procedures; Further Exploratory Research on Protein Adducts. Final report Cooperative Agreement DAMD17-97-2-7002. NTIS number: ADA381035/XAB (2000).
22. D. Noort, A.G. Hulst, H.C. Trap, L.P.A. De Jong and H.P. Benschop, Synthesis and mass spectrometric identification of the major amino acid adduct formed between sulfur mustard and haemoglobin in human blood, Arch. Toxicol., 71, 171-178 (1997).
23. E.O. Price, J.R. Smith, C.R. Clark, J.J. Schlager and M.L. Shih, MALDI-TOF/MS as a diagnostic tool for the confirmation of sulfur mustard exposure, J. Appl. Toxicol., 20, S193-S197 (2002).
24. D. Noort, A.G. Hulst, L.P.A. De Jong and H.P. Benschop, Alkylation of human serum albumin by sulfur mustard in vitro and in vivo: mass spectrometric analysis of a cysteine adduct as a sensitive biomarker of exposure, Chem. Res. Toxicol., 12, 715-721 (1999).
25. W.E. Bechtold, J.K. Willis, J.D. Sun, W.C. Griffith and T.V. Reddy, Biological markers of exposure to benzene: S-phenylcysteine in albumin, Carcinogenesis, 13, 1217-1220 (1992).
26. S. Waidyanatha, K. Yeowell-O'Connell and S.M. Rappaport, A new assay for albumin and hemoglobin adducts of 1,2-and 1,4-benzoquinones, Chem.-Biol. Interact., 115, 117-139 (1998).
27. D. Noort, A. Fidder and A.G. Hulst, Modification of human serum albumin by acrylamide at cysteine-34: basis for a rapid biomonitoring procedure, Arch. Toxicol., 77, 543-545 (2003).
28. D. Noort, A.G. Hulst and R. Jansen, Covalent binding of nitrogen mustards to the cysteine-34 residue in human serum albumin, Arch. Toxicol., 76, 83-88 (2002).
29. W.D. Korte, J.R. Smith, B.R. Capacio, M. DeLion and D.R. Anderson, Monitoring sulfur mustard exposure by the GC-MS analysis of thiodiglycol cleaved from blood proteins', U.S. Army medical research and material command, Proceedings of the 2002 Bioscience Review, Hunt Valley, MD, 269.
30. G.P. Van der Schans, D. Noort, R.H. Mars-Groenendijk, A. Fidder, L.F. Chau, L.P.A. De Jong and H.P. Benschop, Immunochemical detection of sulfur mustard adducts with keratins in the stratum corneum of human skin, Chem. Res. Toxicol., 15, 21-25 (2003).
31. M. Goldman and J.C. Dacre, Lewisite: its chemistry, toxicology, and biological effects, Rev. Environ. Contam. Toxicol., 110, 75-115 (1989).
32. B. Papirmeister, A.J. Feister, S.I. Robinson and R.D. Ford Medical Defense Against Mustard Gas: Toxic Mechanisms and Pharmacological Implications, CRC Press, Boca Raton, 1991.
33. A.P. Watson and G.D. Griffin, Toxicity of vesicant agents scheduled for destruction by the chemical stockpile disposal program, Environ. Health Perspect., 98, 259-280 (1992).
34. H.V. Aposhian, biochemical toxicology of arsenic, Rev. Biochem. Toxicol., 10, 265-299 (1989).
35. A. Fidder, D. Noort, A.G. Hulst, L.P.A. De Jong and H.P. Benschop, Biomonitoring of exposure to lewisite based on adducts to haemoglobin, Arch. Toxicol., 74, 207-214 (2000).
36. R.M. Black and J.M. Harrison, The chemistry of organophosphorus chemical warfare agents, in The Chemistry of Organophosphorus Compounds, Vol. 4, F.R. Hartley (Ed.), John Wiley & Sons, Ltd, New York, 781-840, 1996.
37. H.P. Benschop and L.P.A. De Jong, Toxicokinetics of soman: species variation and stereospecificity in elimination pathways, Neurosci. Biobehav. Rev., 15, 73-77 (1991).
38. A. Ordentlich, D. Barak, C. Kronman, H.P. Benschop, L.P.A. De Jong, N. Ariel, R. Barak, Y. Segall, B. Velan and A. Shafferman, Exploring the active center of human acetylcholinesterase with stereomers of an organophosphorus inhibitor with two chiral centers, Biochemistry, 38, 3055-3066 (1991).
39. D. Barak, A. Ordentlich, D. Kaplan, R. Barak, D. Mizrahi, C. Kronman, Y. Segall, B. Velan and A. Shafferman, Evidence for P-N bond scission in phosphoramidate nerve agent adducts of human acetylcholinesterase, Biochemistry, 39, 1156-1161 (2000).
40. E. Elhanany, A. Ordentlich, O. Dgany, D. Kaplan, Y. Segall, R. Barak, B. Velan and A. Shafferman, Resolving pathways of interaction of covalent inhibitors with the active site of acetylcholinesterases: MALDI-TOF/MS analysis of various nerve agent phosphyl adducts, Chem. Res. Toxicol., 14, 912-918 (2001).
41. H.N. Nigg and J.B. Knaak, Blood cholinesterases as human biomarkers of organophosphorus pesticide exposure, Rev. Environ. Contam. Toxicol., 163, 29-111 (2000).
42. F. Worek, U. Mast, D. Kiderlen, C. Diepold and P. Eyer, Improved determination of acetylcholinesterase activity in human blood, Clin. Chim. Acta, 288, 73-90 (1999).
43. M. Lotti, Cholinesterase inhibition: complexities in interpretation, Clin. Chem., 41, 1814-1818 (1995).
44. M. Polhuijs, J.P. Langenberg and H.P. Benschop, New method for retrospective detection of exposure to organophosphorus anticholinesterases: application to alleged sarin victims of Japanese terrorists, Toxicol. Appl. Pharmacol., 146, 156-161 (1997).
45. E.M. Jakubowski, L.S. Heykamp, H.D. Durst and S.A. Thomson, Preliminary studies in the formation of ethyl methylphosphonofluoridate from rat and human serum exposed to VX and treated with fluoride ion, Anal. Lett., 34, 727-737 (2001).
46. M. Nagao, T. Takatori, Y. Matsuda, M. Nakajima, H. Iwase and K. Iwadate, Definitive evidence for the acute sarin poisoning diagnosis in the Tokyo subway, Toxicol. Appl. Pharmacol., 144, 198-203 (1997).
47. Y. Matsuda, M. Nagao, T. Takatori, H. Niijima, M. Nakajima, H. Iwase, M. Kobayashi and K. Iwadate, Detection of sarin hydrolysis product in formalin-fixed brain tissues of victims of the Tokyo subway terrorist attack, Toxicol. Appl. Pharmacol., 150, 310-320 (1998).
48. A. Fidder, D. Noort, A.G. Hulst, R. De Ruiter, M.J. Van der Schans, H.P. Benschop and J.P. Langenberg, Retrospective detection of exposure to organophosphorus anti-cholinesterases: mass spectrometric analysis of phosphylated human butyrylcholinesterase, Chem. Res. Toxicol., 15, 582-590 (2002).
49. J.A. Doorn, D.A. Gage, M. Schall, T.T. Talley, C.M. Thompson and R.J. Richardson, Inhibition of acetylcholinesterase by (1S, 3S)-isomalathion proceeds with loss of thiomethyl: Kinetic and Mass Spectral Evidence for an Unexpected Primary Leaving Group, Chem. Res. Toxicol., 13, 1313-1320 (2000).
50. J.A. Doorn, M. Schall, D.A. Gage, T.T. Talley, C.M. Thompson and R.J. Richardson, Identification of butyrylcholinesterase adducts after inhibition with Isomalathion using mass spectrometry: difference in mechanism between (1R) and (1S)-Stereoisomers, Toxicol. Appl. Pharmacol., 176, 73-80 (2001).
51. R.M. Black, J.M. Harrison and R.W. Read, The interaction of sarin and soman with plasma proteins: the identification of a novel phosphylation site, Arch. Toxicol., 73, 123-126 (1999).
52. T. Murachi, A general reaction of disopropylphosphorofluoridate with proteins without direct effect on enzymic activities, Biochim. Biophys. Acta, 71, 239-241 (1963).
53. D. Noort, A.G. Hulst, A. Fidder, R.A. Van Gurp, L.P.A. De Jong and H.P. Benschop, In vitro adduct formation of phosgene with albumin and hemoglobin in human blood, Chem. Res. Toxicol., 13, 719-726 (2000).
54. L.R. Pohl, B. Bhooshan, N.F. Whittaker and G. Krishna, Phosgene: a metabolite of chloroform, Biochem. Biophys. Res. Commun., 79, 684-691 (1977).
55. L. Fabrizi, G.W. Taylor, B. Canas, A.R. Boobis and J. Edwards, Adduction of the chloroform metabolite phosgene to lysine residues of human histone H2B, Chem. Res. Toxicol., 16, 266-275 (2003).
56. G.L. Ellman, K.D. Courtney and V. Anders, A new and rapid colorimetric determination of acetylcholinesterase activity, Biochem. Pharmacol., 7, 88-95 (1961).